CSF3 and Decreased total neutrophil count: All patients in this study received prophylaxis leukocyte therapy using recombinant granulocyte colony-stimulating factor (GCFS), and patients who experienced grade 3/4 leukocytopenia and neutropenia during IC and could therefore continue with chemotherapy without delay.